Oxford COVID-19 vaccine trial: The coronavirus vaccine created by the University of Oxford appears safe and has shown a protective immune response in hundreds of people who got the shot in an early trial, scientists announced on Monday after the first phase of human trials.
British researchers involved in the Oxford COVID-19 vaccine trial had first begun testing the Coronavirus vaccine in April this year in about 1,000 people.
Half of these volunteers got the experimental vaccine, an AP report said. Such early trials are usually designed only to evaluate the safety, but in this case, the experts were also looking to see what kind of immune response was provoked, the report added.
In the research that was published on Monday in The Lancet journal, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. “We are seeing good immune response in
You’ve reached your free article limit
Subscribe to enjoy unlimited access to trusted journalism. Cancel anytime.
Subscribe nowNeed help? molokom@insidepolitic.co.za
